Wybierz wielkość
| Gabaryty przesyłki | SKU | Dostępność | Cena netto |
|---|---|---|---|
| 100 μg | Sprawdź dostępność w koszyku | 1960,00 zł |
Informacje o tej pozycji
biological source
rat
Quality Level
antibody form
purified immunoglobulin
antibody product type
primary antibodies
clone
3E8, monoclonal
species reactivity
mouse
species reactivity (predicted by homology)
human (based on 100% sequence homology)
technique(s)
ChIP: suitable, ELISA: suitable, western blot: suitable
isotype
IgG2aκ
NCBI accession no.
UniProt accession no.
shipped in
wet ice
target post-translational modification
phosphorylation (pSer5)
Gene Information
human ... POLR2B(5431)
General description
Immunogen
Application
Epigenetyka i funkcje jądrowe
Epigenetyka i funkcje jądrowe
Czynniki transkrypcyjne
Metabolizm i wiązanie białek RNA
Biochem/physiol Actions
Physical form
Preparation Note
Analysis Note
Fosfataza białkowa γ (γ-Ppase) nieleczone i leczone lizaty komórek NIH/3T3
Western Blot Analysis: 1 µg/ml of this antibody detected RNA polymerase II CTD on 10 µg of γ-PPase untreated and treated NIH/3T3 cell lysates.
Other Notes
Disclaimer
1 of 1
Ta pozycja | |||
|---|---|---|---|
| biological source rat | biological source rat | biological source rat | biological source rat |
| antibody form purified immunoglobulin | antibody form purified immunoglobulin | antibody form culture supernatant | antibody form purified immunoglobulin |
| clone 3E8, monoclonal | clone 3E10, monoclonal | clone 3E8, monoclonal | clone 4E12, monoclonal |
| species reactivity mouse | species reactivity mouse | species reactivity mouse | species reactivity mouse |
| Gene Information human ... POLR2B(5431) | Gene Information human ... POLR2B(5431) | Gene Information human ... POLR2B(5431) | Gene Information human ... POLR2B(5431) |
| UniProt accession no. | UniProt accession no. | UniProt accession no. | UniProt accession no. |
Still not finding the right product?
Explore all of our products under Przeciwciało przeciwko podjednostce B1 polimerazy II RNA (fosfo-CTD Ser-5), klon 3E8
— lub —
Wypróbuj nasze narzędzie Narzędzie selektora produktów, aby zawęzić opcje.
Klasa składowania
12 - Non Combustible Liquids
wgk
WGK 1
Certyfikaty analizy (CoA)
Poszukaj Certyfikaty analizy (CoA), wpisując numer partii/serii produktów. Numery serii i partii można znaleźć na etykiecie produktu po słowach „seria” lub „partia”.
Masz już ten produkt?
Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.
Powiązane treści
Cancer is a complex disease manifestation. At its core, it remains a disease of abnormal cellular proliferation and inappropriate gene expression. In the early days, carcinogenesis was viewed simply as resulting from a collection of genetic mutations that altered the gene expression of key oncogenic genes or tumor suppressor genes leading to uncontrolled growth and disease (Virani, S et al 2012). Today, however, research is showing that carcinogenesis results from the successive accumulation of heritable genetic and epigenetic changes. Moreover, the success in how we predict, treat and overcome cancer will likely involve not only understanding the consequences of direct genetic changes that can cause cancer, but also how the epigenetic and environmental changes cause cancer (Johnson C et al 2015; Waldmann T et al 2013). Epigenetics is the study of heritable gene expression as it relates to changes in DNA structure that are not tied to changes in DNA sequence but, instead, are tied to how the nucleic acid material is read or processed via the myriad of protein-protein, protein-nucleic acid, and nucleic acid-nucleic acid interactions that ultimately manifest themselves into a specific expression phenotype (Ngai SC et al 2012, Johnson C et al 2015). This review will discuss some of the principal aspects of epigenetic research and how they relate to our current understanding of carcinogenesis. Because epigenetics affects phenotype and changes in epigenetics are thought to be key to environmental adaptability and thus may in fact be reversed or manipulated, understanding the integration of experimental and epidemiologic science surrounding cancer and its many manifestations should lead to more effective cancer prognostics as well as treatments (Virani S et al 2012).
Numer pozycji handlu globalnego
| SKU | NUMER GTIN |
|---|---|
| 04-1572 | 04053252650376 |



